Keywords in this edition: Current case report, WHO - Annual pharmacovigilance meeting, Medicinal product risks, Information for patients, Collaboration on the safety of medicines
As of 1 January 2019, anyone who produces, sells or distributes medicinal products is required by law to report to Swissmedic any suspicion of illegal trading in such products.
Rückruf der Charge HX3438 bis auf Stufe Patient
These products shall in future come under the therapeutic products legislation in Switzerland
Fälle von immunbedingter Myositis im Zusammenhang mit Tecentriq®
Communications regarding the safety of medicines
Product groups, services
Stay up to date
Our news subscription service provides on-going information via e-mail.
Reporting undesirable effects
Reporting incidents & FSCAs
The modifications following the ordinary revision of the TPA and its right of enforcement will enter into force on 1 January 2019
What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.
Swissmedic monitors all safety measures and recalls for medical devices that are manufactured or marketed in Switzerland.
Swissmedic, Swiss Agency for Therapeutic Products
Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.
For further information...